Proton radiation registry study for adults with lymphoma
Part of Blood & lymphatic, Cancer clinical trials.
This study collects information about adults with lymphoma who need treatment that targets the chest/mediastinum. It focuses on how proton radiation may help protect the heart, lungs, and breast compared with the more common photon radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have lymphoma confirmed by a pathology test (biopsy) called WHO diagnosis
- Your doctor must believe you need chest/mediastinal radiation, and that protons could help more than standard radiation
- You must be able and willing to provide consent
- You must not refuse the study or withdrawal of participation must not have happened
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests proton therapy, a precise type of radiation, to treat lymphoma in the chest. The goal is to reduce damage to healthy organs while still curing the cancer.
This trial studies the effects of radiation therapy on the chest area (mediastinum) in patients with lymphoma or thymoma. It aims to see how well modern radiation works after chemotherapy and may help improve treatment outcomes.
This trial studies proton radiotherapy (a type of radiation) for cancers of the thymus, like thymoma or thymic carcinoma. It may help improve tumor control while limiting radiation exposure to nearby organs.
This study looks at a type of radiation treatment using proton beams (IMPT) for small cell lung cancer. It may help assess whether this approach can safely deliver the planned radiation doses to the chest.
This registry collects information from people who have conditions that may be treated with radiation therapy (proton or standard X-ray radiation). It helps the clinic better understand patients’ care and outcomes, and joining requires signing consent.
This study keeps a record of patients who receive proton radiation therapy at a specific center. It may help doctors learn how this treatment is used and how patients do over time.
Hear when a new Mediastinal Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.